Review of Tolvaptan for Autosomal Dominant Polycystic Kidney Disease
Author:
Affiliation:
1. University at Buffalo School of Pharmacy and Pharmaceutical Sciences; Buffalo New York
Publisher
Wiley
Subject
Pharmacology (medical)
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/phar.1421/fullpdf
Reference68 articles.
1. Clinical practice. Autosomal dominant polycystic kidney disease;Grantham;N Engl J Med,2008
2. Autosomal dominant polycystic kidney disease;Torres;Lancet,2007
3. Autosomal dominant polycystic kidney disease: the last 3 years;Torres;Kidney Int,2009
4. Autosomal dominant polycystic kidney disease: emerging concepts of pathogenesis and new treatments;Braun;Cleve Clin J Med,2009
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chronic endothelial dopamine receptor stimulation improves endothelial function and hemodynamics in autosomal dominant polycystic kidney disease;Kidney International;2024-08
2. Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease;The Korean Journal of Internal Medicine;2023-05-01
3. Efficacy and safety of tolvaptan versus placebo in the treatment of patients with autosomal dominant polycystic kidney disease: a meta-analysis;International Urology and Nephrology;2022-09-07
4. Clinical Utility and Tolerability of Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD);Drug, Healthcare and Patient Safety;2022-09
5. Restoration of atypical protein kinase C ζ function in autosomal dominant polycystic kidney disease ameliorates disease progression;Proceedings of the National Academy of Sciences;2022-07-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3